Radiopharm Theranostics Limited (ASX:RAD) Financings
Financings
| Raise | Date | In US dollars |
|---|---|---|
| Share purchase plan of sPP Shares with SPP Attaching Options Closed: A$3M raised · A$0.009 a share · Warrants at A$0.018 Buyers: Trading Capital Management (HK) Ltd (~A$1.5 million pursuant to a shortfall commitment) Insiders: ~A$0.1 million subscribed by participating Directors Use of proceeds: RAD101 registrational study, advancing therapeutic programs, strategic partnering, working capital and general corporate purposes | Sep 17, 2026 | US$2.13M |
| Registered direct offering of american Depositary Shares with unregistered warrants Announced: about US$4.1M · US$3.16 a share · Warrants at US$3.79 · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: RAD101 registrational study, advancing therapeutic programs, strategic partnering, working capital and general corporate purposes | Jul 27, 2026 | |
| Private placement of ordinary shares with attaching options Announced: about A$6.7M · Warrants at A$0.018 Use of proceeds: RAD101 registrational study, advancing therapeutic programs, strategic partnering, working capital and general corporate purposes | Jul 27, 2026 | US$4.68M |